Lonza Group AG (LONN.SW)
- PR Newswire
Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to BigHat Biosciences, Inc. ("BigHat"). BigHat will combine Synaffix technology with its world-class ML antibody design platform for the development of a new ADC pipeline program.
- Insider Monkey
Lonza Group AG (LZAGY): Among UBS’ Top Tech Based Disruptive Stocks For 2030
We recently compiled a list of the UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks. In this article, we are going to take a look at where Lonza Group AG (OTC:LZAGY) stands against the other tech based disruptive stocks. When it comes to investing and making massive gains on the stock market, disruption […]
